LB
About
LimmaTech Biologics is a clinical-stage biotech company that develops vaccines to prevent life-threatening diseases. The company uses proprietary self-adjuvanting and multi-antigen vaccine platforms to address microbial infections that are becoming resistant to treatments. Its research and development efforts aim to create vaccines tailored to specific pathogens. LimmaTech Biologics works on expanding its pipeline to provide solutions for infectious diseases with limited treatment options.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 8 investors are based in Schlieren, Zurich, Switzerland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Schlieren, Switzerland
Contact Information
linkedin.com/in/••••••••
Find more investors like LimmaTech
Search Investors